Trends in diabetes medication use in Australia, Canada, England, and Scotland: a repeated cross-sectional analysis in primary care

BACKGROUND: Several new classes of glucose-lowering medications have been introduced in the past two decades. Some, such as sodium-glucose cotransporter 2 inhibitors (SGLT2s), have evidence of improved cardiovascular outcomes, while others, such as dipeptidyl peptidase-4 inhibitors (DPP4s), do not....

Descripción completa

Detalles Bibliográficos
Autores principales: Greiver, Michelle, Havard, Alys, Bowles, Juliana KF, Kalia, Sumeet, Chen, Tao, Aliarzadeh, Babak, Moineddin, Rahim, Sherlock, Julian, Hinton, William, Sullivan, Frank, O’Neill, Braden, Pow, Conrad, Bhatt, Aashka, Rahman, Fahurrozi, Meza-Torres, Bernardo, Litchfield, Melisa, de Lusignan, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906622/
https://www.ncbi.nlm.nih.gov/pubmed/33619050
http://dx.doi.org/10.3399/bjgp20X714089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906622/
https://www.ncbi.nlm.nih.gov/pubmed/33619050
http://dx.doi.org/10.3399/bjgp20X714089

Ejemplares similares